Insights

Europe expansion OM1’s announced expansion into Europe signals growing demand for AI-driven real-world data solutions across global markets. Sales teams should target regulated markets and pharma/hospitals seeking compliant RWE partnerships and regional support.

AI powered differentiation OM1 emphasizes AI-driven, regulatory-grade longitudinal data and personalized medicine platforms. This positions them to pursue large biopharma and payer opportunities needing scalable, AI-enabled evidence generation for trials, market access, and outcomes research.

RWE leadership Recognition for real-world evidence analytics and new product innovation indicates strong credibility with life sciences customers. Focus on upsell to existing clients and cross-sell adjacent datasets and tools (CRS, asthma datasets) to expand footprint.

Product portfolio Launch of multiple AI-powered products (OM1 Orion, Lyra, Polaris) and phenotyping platform suggests opportunities for bundled offerings and enterprise licensing to streamline clinical trial matching, patient stratification, and observational studies.

Strategic leadership New leadership with Global GM hire and a growth-oriented narrative underscores readiness to scale partnerships with large networks, CROs, and global pharma accounts—ideal for targeted executive outreach and co-development ventures.

Similar companies to OM1, Inc.

OM1, Inc. Tech Stack

OM1, Inc. uses 8 technology products and services including HubSpot Analytics, Apache Spark, Tableau, and more. Explore OM1, Inc.'s tech stack below.

Media & News

OM1, Inc.'s Email Address Formats

OM1, Inc. uses at least 4 email formats:
OM1, Inc. Email FormatsExamplePercentage
FLast@om1.comJDoe@om1.com
95%
First@om1.comJohn@om1.com
3%
First.Last@om1.comJohn.Doe@om1.com
1%
FirstLast@om1.comJohnDoe@om1.com
1%

Frequently Asked Questions

What is OM1, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact OM1, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is OM1, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
OM1, Inc.'s official website is om1.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does OM1, Inc. generate?

Minus sign iconPlus sign icon
As of October 2026, OM1, Inc.'s annual revenue is estimated to be $25M - $50M.

What is OM1, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
OM1, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does OM1, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2026, OM1, Inc. has approximately 94 employees across 4 continents, including North America, Asia and Europe. Key team members include Vice President And Head Of Operations: O. P., Vice President Of Product Management: A. P. and President & Coo: C. R. Explore OM1, Inc.'s employee directory with LeadIQ.

What industry does OM1, Inc. belong to?

Minus sign iconPlus sign icon
OM1, Inc. operates in the Biotechnology Research industry.

What technology does OM1, Inc. use?

Minus sign iconPlus sign icon
OM1, Inc.'s tech stack includes HubSpot Analytics, Apache Spark, Tableau, Apache Airflow, WordPress, Epic Systems, Vercel and Zoom.

What is OM1, Inc.'s email format?

Minus sign iconPlus sign icon
OM1, Inc.'s email format typically follows the pattern of FLast@om1.com. Find more OM1, Inc. email formats with LeadIQ.

How much funding has OM1, Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2026, OM1, Inc. has raised $171M in funding. The last funding round occurred on Jul 16, 2021 for $85M.

When was OM1, Inc. founded?

Minus sign iconPlus sign icon
OM1, Inc. was founded in 2015.
OM1, Inc. logo

OM1, Inc.

Biotechnology ResearchMassachusetts, United States51-200 Employees

OM1, Inc. is a mid-sized biotechnology research company based in Boston, focused on real-world evidence and personalized medicine through data-driven insights. It combines regulatory-grade longitudinal data with advanced analytics to turn real-world observations into actionable knowledge for researchers and clinicians. The company aims to move real-world evidence from research into practical patient care and to advance scientific understanding.

Its customers include pharmaceutical and healthcare organizations seeking AI-enhanced RWE solutions to inform development, outcomes research, and payer and provider decision-making. OM1 is positioned in the biotechnology research landscape as a leader in integrating AI and data technologies to transform how real-world evidence is used across the industry. In 2025, the company expanded its footprint into Europe to better support its clients with its real-world evidence capabilities.

Section iconCompany Overview

Phone number
Website
om1.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $171M

    OM1, Inc. has raised a total of $171M of funding over 4 rounds. Their latest funding round was raised on Jul 16, 2021 in the amount of $85M as a Series D.

  • $25M - $50M

    OM1, Inc.'s revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.